About ConsumerLab.com

Posted April 2, 2021

Seller of Vision Supplements Warned by FDA

On March 19, 2021, the FDA issued a warning letter to Lipotriad LLC following a review of the company's websites, which found statements made about the company's products Lipotriad Visionary, Lipotriad Adult 50+, Lipotriad Dry Eye, and Lipotriad Vision Support Plus to be drug claims.

Lipotriad Adult 50+ was promoted with statements such as "DOUBLE THE LUTEIN (10mg) & 2.5mg ZEAXANTHIN: Our Adult 50+ Formula contains double the lutein when compared to leading Adult 50+ Eye Vitamin Formulas. These ingredients protect the macula and filter out harmful blue rays."

See ConsumerLab's Vision Supplements Review (with Lutein and Zeaxanthin) for tests of related products.

Lipotriad Visionary was promoted with statements such as "In addition supplementing with fish oil has led to a lower risk of heart disease and a reduction of chronic inflammation that can lead to a variety of serious diseases, including cancer and stroke."

See ConsumerLab's Fish Oil, Krill Oil, and Algal Oil Omega-3 (DHA & EPA) Supplements Review for tests of related products.

Lipotriad Dry Eye was promoted with statements such as "Recommended for:... Dry Eye Support."

See ConsumerLab's answer to the question Can supplements improve symptoms of dry eye? for more information.

In addition, the Lipotriad products were found to be misbranded because they do not contain adequate directions for safe use, as required by federal regulations.

For more information, use the link below.

Warning Letter: Lipotriad LLC

See Related Warnings:

Seller of Omega-3, Ginkgo, Vision Supplements & More Warned for Drug Claims

Seller of Vision Supplements Warned for Drug Claims

Seller of Vision Supplements Warned for Manufacturing Violations, Drug Claims

CVS Settles Lawsuit Over Claims Its Omega-3 Supplement Improves Memory